Convergence Investment Partners’s ResMed RMD Stock Holding History

Convergence Investment Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,288	Closed	-$551K	–	276
2025 Q4	$551K	Sell	2,288 -3,328	-59%	-$851K	0.11%	203
2025 Q3	$1.54M	Buy	5,616 +669	+14%	+$183K	0.35%	96
2025 Q2	$1.28M	Buy	+4,947	New	+$1.18M	0.32%	111
2025 Q1	–	Sell	-4,487	Closed	-$1.03M	–	300
2024 Q4	$1.03M	Buy	+4,487	New	+$1.08M	0.23%	144
2018 Q2	–	Sell	-89	Closed	-$9K	–	768
2018 Q1	$9K	Buy	+89	New	+$8.41K	﹤0.01%	721

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Convergence Investment Partners's RMD Position: Q1 2026 in Review

Convergence Investment Partners sold out of ResMed (RMD) in Q1 2026, closing a stake of 2,288 shares — an estimated $551K sold.

Convergence Investment Partners first reported a position in RMD in Q1 2018 and held it in 5 quarters. The position peaked at $1.54M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Convergence Investment Partners reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Convergence Investment Partners sold 2,288 ResMed shares in Q1 2026, an estimated $551K.
Convergence Investment Partners first reported a position in ResMed in Q1 2018 and held it in 5 quarters.
Convergence Investment Partners's ResMed position peaked at $1.54M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Convergence Investment Partners's 13F filing for Q1 2026, filed 7 May 2026.